PMID- 22476201 OWN - NLM STAT- MEDLINE DCOM- 20120731 LR - 20240506 IS - 1552-9924 (Electronic) IS - 0091-6765 (Print) IS - 0091-6765 (Linking) VI - 120 IP - 4 DP - 2012 Apr TI - Cross-regulations among NRFs and KEAP1 and effects of their silencing on arsenic-induced antioxidant response and cytotoxicity in human keratinocytes. PG - 583-9 LID - 10.1289/ehp.1104580 [doi] AB - BACKGROUND: Nuclear factor E2-related factors (NRFs), including NRF2 and NRF1, play critical roles in mediating the cellular adaptive response to oxidative stress. Human exposure to inorganic arsenic, a potent oxidative stressor, causes various dermal disorders, including hyperkeratosis and skin cancer. OBJECTIVE: We investigated the cross-regulations among NRF2, NRF1, and KEAP1, a cullin-3-adapter protein that allows NRF2 to be ubiquinated and degraded by the proteasome complex, in arsenic-induced antioxidant responses. RESULTS: In human keratinocyte HaCaT cells, selective knockdown (KD) of NRF2 by lentiviral short hairpin RNAs (shRNAs) significantly reduced the expression of many antioxidant enzymes and sensitized the cells to acute cytotoxicity of inorganic arsenite (iAs(3+)). In contrast, silencing KEAP1 led to a dramatic resistance to iAs(3+)-induced apoptosis. Pretreatment of HaCaT cells with NRF2 activators, such as tert-butylhydroquinone, protects the cells against acute iAs(3+) toxicity in an NRF2-dependent fashion. Consistent with the negative regulatory role of KEAP1 in NRF2 activation, KEAP1-KD cells exhibited enhanced transcriptional activity of NRF2 under nonstressed conditions. However, deficiency in KEAP1 did not facilitate induction of NRF2-target genes by iAs(3+). In addition, NRF2 silencing reduced the expression of KEAP1 at transcription and protein levels but increased the protein expression of NRF1 under the iAs(3+)-exposed condition. In contrast, silencing KEAP1 augmented protein accumulation of NRF2 under basal and iAs3+-exposed conditions, whereas the iAs(3+)-induced protein accumulation of NRF1 was attenuated in KEAP1-KD cells. CONCLUSIONS: Our studies suggest that NRF2, KEAP1, and NRF1 are coordinately involved in the regulation of the cellular adaptive response to iAs(3+)-induced oxidative stress. FAU - Zhao, Rui AU - Zhao R AD - School of Forensic Medicine, China Medical University, Shenyang, China. FAU - Hou, Yongyong AU - Hou Y FAU - Zhang, Qiang AU - Zhang Q FAU - Woods, Courtney G AU - Woods CG FAU - Xue, Peng AU - Xue P FAU - Fu, Jingqi AU - Fu J FAU - Yarborough, Kathy AU - Yarborough K FAU - Guan, Dawei AU - Guan D FAU - Andersen, Melvin E AU - Andersen ME FAU - Pi, Jingbo AU - Pi J LA - eng GR - R01 ES016005/ES/NIEHS NIH HHS/United States GR - ES016005/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20120103 PL - United States TA - Environ Health Perspect JT - Environmental health perspectives JID - 0330411 RN - 0 (Antioxidants) RN - 0 (Arsenites) RN - 0 (Environmental Pollutants) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (KEAP1 protein, human) RN - 0 (Kelch-Like ECH-Associated Protein 1) RN - 0 (NF-E2-Related Factor 1) RN - 0 (NF-E2-Related Factor 2) RN - 0 (RNA, Small Interfering) RN - 0 (Sodium Compounds) RN - 48OVY2OC72 (sodium arsenite) RN - N712M78A8G (Arsenic) SB - IM MH - Antioxidants/*metabolism MH - Apoptosis MH - Arsenic/*pharmacology MH - Arsenites/pharmacology MH - Blotting, Western MH - Cell Line MH - Dose-Response Relationship, Drug MH - Environmental Pollutants/*toxicity MH - Flow Cytometry MH - Gene Knockdown Techniques MH - Humans MH - Intracellular Signaling Peptides and Proteins/genetics/*metabolism MH - Kelch-Like ECH-Associated Protein 1 MH - Keratinocytes/cytology/*drug effects/physiology MH - Lentivirus MH - NF-E2-Related Factor 1/genetics/*metabolism MH - NF-E2-Related Factor 2/genetics/*metabolism MH - Oxidative Stress MH - RNA, Small Interfering/metabolism MH - Real-Time Polymerase Chain Reaction MH - Reverse Transcriptase Polymerase Chain Reaction MH - Skin Diseases/chemically induced/physiopathology MH - Sodium Compounds/pharmacology PMC - PMC3339469 COIS- The content is solely the responsibility of the authors. All authors have agreed to its content. M.E.A. received some funding from Dow Chemical Company. All of the other authors declare they have no actual or potential competing financial interests. EDAT- 2012/04/06 06:00 MHDA- 2012/08/01 06:00 PMCR- 2012/04/01 CRDT- 2012/04/06 06:00 PHST- 2011/10/04 00:00 [received] PHST- 2012/01/03 00:00 [accepted] PHST- 2012/04/06 06:00 [entrez] PHST- 2012/04/06 06:00 [pubmed] PHST- 2012/08/01 06:00 [medline] PHST- 2012/04/01 00:00 [pmc-release] AID - ehp.1104580 [pii] AID - 10.1289/ehp.1104580 [doi] PST - ppublish SO - Environ Health Perspect. 2012 Apr;120(4):583-9. doi: 10.1289/ehp.1104580. Epub 2012 Jan 3.